1. Ribavirin/sofosbuvir

   Case report 21 November 2020 Pages: 251 - 251

2. Ritonavir

   Case report 21 November 2020 Pages: 252 - 252

3. Rituximab/tocilizumab

   Case report 21 November 2020 Pages: 253 - 253

4. Rituximab/tocilizumab

   Case report 21 November 2020 Pages: 254 - 254

5. Rivaroxaban

   Case report 21 November 2020 Pages: 255 - 255

6. Rivaroxaban

   Case report 21 November 2020 Pages: 256 - 256

7. Salbutamol

   Case report 21 November 2020 Pages: 257 - 257

8. Secukinumab

   Case report 21 November 2020 Pages: 258 - 258

9. Sintilimab/granulocyte-macrophage-colony-stimulating-factor

   Case report 21 November 2020 Pages: 259 - 259

10. Somatrogon

    Case report 21 November 2020 Pages: 260 - 260

11. Sorafenib

    Case report 21 November 2020 Pages: 261 - 261

12. Tamoxifen

    Case report 21 November 2020 Pages: 262 - 262

13. Terbinafine

    Case report 21 November 2020 Pages: 263 - 263

14. Terbinafine

    Case report 21 November 2020 Pages: 264 - 264

15. Teriflunomide

    Case report 21 November 2020 Pages: 265 - 265

16. Teriflunomide

    Case report 21 November 2020 Pages: 266 - 266

17. Tirofiban

    Case report 21 November 2020 Pages: 267 - 267

18. Tizanidine

    Case report 21 November 2020 Pages: 268 - 268

19. Tocilizumab

    Case report 21 November 2020 Pages: 269 - 269

20. Tocilizumab

    Case report 21 November 2020 Pages: 270 - 270

21. Tocilizumab

    Case report 21 November 2020 Pages: 271 - 271

22. Upadacitinib

    Case report 21 November 2020 Pages: 272 - 272

23. Vk-5211 abuse

    Case report 21 November 2020 Pages: 273 - 273

24. Vonoprazan

    Case report 21 November 2020 Pages: 274 - 274

25. Warfarin

    Case report 21 November 2020 Pages: 275 - 275

26. Warfarin

    Case report 21 November 2020 Pages: 276 - 276

27. Non-serious case reports

    News item 21 November 2020 Pages: 277 - 278